Local removal for early rectal cancer without extra treatment
Part of Cancer, Digestive system clinical trials.
This trial studies removing an early rectal cancer tumor locally (through the rectum/anal area) with no additional therapy afterward. The goal is to preserve organs and maintain quality of life while still trying to cure the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your tumor is rectal cancer of a specific type: adenocarcinoma
- Your tumor is early stage: cT1N0M0 (no spread to lymph nodes or distant organs)
- The tumor is small and low in the rectum: up to 3 cm wide, and within 2 cm of the anal opening
- Your scans and/or scope findings suggest the tumor is only in the top sub-layer (not into the muscle layer)
- You are not planning additional treatments like combined chemo and radiation after local removal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
This study looks at whether giving radiation or chemoradiation after removing an early-stage rectal cancer can improve outcomes for patients who choose not to have standard surgery to remove the whole rectum. It aims to see how well this approach works in real-world practice.
This trial tests whether people with early- to intermediate-stage low rectal cancer can avoid surgery if their tumor responds well to a full course of chemotherapy and radiation. It starts with brief chemotherapy, then adjusts treatment based on how much the tumor shrinks.
This trial tests whether some people with locally advanced rectal cancer can safely avoid surgery after chemoradiotherapy. If the tumor disappears, patients may be monitored closely instead of having an operation, which could help preserve the anus.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.